Outset Medical Inc. logo

Outset Medical Inc. (OM)

Market Open
4 Jun, 17:16
NASDAQ (NGS) NASDAQ (NGS)
$
4. 84
+0.24
+5.2174%
$
93.98M Market Cap
- P/E Ratio
- Div Yield
137,194 Volume
-2.74 Eps
$ 4.6
Previous Close
Add Transaction
Day Range
4.6 5.1
Year Range
3 21.98
Want to track OM and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Investors in Outset Medical, Inc. Should Contact Levi & Korsinsky Before October 28, 2024 to Discuss Your Rights - OM

Investors in Outset Medical, Inc. Should Contact Levi & Korsinsky Before October 28, 2024 to Discuss Your Rights - OM

NEW YORK, NY / ACCESSWIRE / September 29, 2024 / If you suffered a loss on your Outset Medical, Inc. (NASDAQ:OM) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: Click Here or contact Joseph E. Levi, Esq.

Accesswire | 1 year ago
OM SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Outset Medical, Inc. Shareholders Have Opportunity to Lead Class Action Lawsuit!

OM SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Outset Medical, Inc. Shareholders Have Opportunity to Lead Class Action Lawsuit!

NEW YORK CITY, NY / ACCESSWIRE / September 29, 2024 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Outset Medical, Inc. ("Outset Medical" or "the Company") (NASDAQ:OM) and certain of its officers. Class Definition This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Outset Medical securities between August 1, 2022, and August 7, 2024, inclusive (the "Class Period").

Accesswire | 1 year ago
Outset Medical, Inc. Sued for Securities Law Violations – Investors Should Contact Levi & Korsinsky for More Information - OM

Outset Medical, Inc. Sued for Securities Law Violations – Investors Should Contact Levi & Korsinsky for More Information - OM

NEW YORK, NY / ACCESSWIRE / September 28, 2024 / If you suffered a loss on your Outset Medical, Inc. (NASDAQ:OM) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: Click Here or contact Joseph E. Levi, Esq.

Accesswire | 1 year ago
Outset Medical Inc Is Being Sued For Possible Securities Fraud And Affected Shareholders Are Urged To Assist The Schall Law Firm

Outset Medical Inc Is Being Sued For Possible Securities Fraud And Affected Shareholders Are Urged To Assist The Schall Law Firm

LOS ANGELES, CA / ACCESSWIRE / September 28, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Outset Medical, Inc. ("Outset" or "the Company") (NASDAQ:OM) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between August 1, 2022 and August 7, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before October 28, 2024.

Accesswire | 1 year ago
Outset Medical, Inc. Sued for Securities Law Violations – Investors Should Contact Levi & Korsinsky for More Information – OM

Outset Medical, Inc. Sued for Securities Law Violations – Investors Should Contact Levi & Korsinsky for More Information – OM

NEW YORK, NY / ACCESSWIRE / September 27, 2024 / If you suffered a loss on your Outset Medical, Inc. (NASDAQ:OM) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: Click Here or contact Joseph E. Levi, Esq.

Accesswire | 1 year ago
Levi & Korsinsky Reminds Outset Medical, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 28, 2024 – OM

Levi & Korsinsky Reminds Outset Medical, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of October 28, 2024 – OM

NEW YORK, NY / ACCESSWIRE / September 27, 2024 / If you suffered a loss on your Outset Medical, Inc. (NASDAQ:OM) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: Click Here or contact Joseph E. Levi, Esq.

Accesswire | 1 year ago
Outset Medical, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before October 28, 2024 to Discuss Your Rights - OM

Outset Medical, Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before October 28, 2024 to Discuss Your Rights - OM

NEW YORK, NY / ACCESSWIRE / September 27, 2024 / If you suffered a loss on your Outset Medical, Inc. (NASDAQ:OM) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: Click Here or contact Joseph E. Levi, Esq.

Accesswire | 1 year ago
SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Outset Medical, Inc. - OM

SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Outset Medical, Inc. - OM

NEW YORK, NY / ACCESSWIRE / September 27, 2024 / Pomerantz LLP announces that a class action lawsuit has been filed against Outset Medical, Inc. ("Outset Medical" or the "Company") (NASDAQ:OM). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext.

Accesswire | 1 year ago
Levi & Korsinsky Notifies Shareholders of Outset Medical, Inc.(OM) of a Class Action Lawsuit and an Upcoming Deadline

Levi & Korsinsky Notifies Shareholders of Outset Medical, Inc.(OM) of a Class Action Lawsuit and an Upcoming Deadline

NEW YORK, NY / ACCESSWIRE / September 27, 2024 / If you suffered a loss on your Outset Medical, Inc. (NASDAQ:OM) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: Click Here or contact Joseph E. Levi, Esq.

Accesswire | 1 year ago
The Schall Law Firm Invites Investor Participation In A Case Against Outset Medical, Inc. For Violating Securities Laws

The Schall Law Firm Invites Investor Participation In A Case Against Outset Medical, Inc. For Violating Securities Laws

LOS ANGELES, CA / ACCESSWIRE / September 27, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Outset Medical, Inc. ("Outset" or "the Company") (NASDAQ:OM) for violations of 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's securities between August 1, 2022 and August 7, 2024, inclusive (the "Class Period"), are encouraged to contact the firm before October 28, 2024.

Accesswire | 1 year ago
Outset Medical, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - OM

Outset Medical, Inc. Sued for Securities Law Violations - Investors Should Contact Levi & Korsinsky for More Information - OM

NEW YORK, NY / ACCESSWIRE / September 27, 2024 / If you suffered a loss on your Outset Medical, Inc. (NASDAQ:OM) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: Click Here or contact Joseph E. Levi, Esq.

Accesswire | 1 year ago
Contact Levi & Korsinsky by October 28, 2024 Deadline to Join Class Action Against Outset Medical, Inc. (OM)

Contact Levi & Korsinsky by October 28, 2024 Deadline to Join Class Action Against Outset Medical, Inc. (OM)

NEW YORK, NY / ACCESSWIRE / September 27, 2024 / If you suffered a loss on your Outset Medical, Inc. (NASDAQ:OM) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: Click Here or contact Joseph E. Levi, Esq.

Accesswire | 1 year ago
Loading...
Load More